Seeking Alpha

Roche (RHHBY.OB) has, for the first time, agreed to let scientists examine hundreds of pages of...

Roche (RHHBY.OB) has, for the first time, agreed to let scientists examine hundreds of pages of clinical trial data for Tamiflu. Some have suggested the flu treatment — which brought in $3.4B in revenue during the Swine Flu panic of 2009 — contributes to suicidal thoughts, a claim Roche strongly denies. The data will be made available after it is edited "to ensure patient confidentiality." 
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs